PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts
PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts
复制标题
DOI:
10.1016/j.yexmp.2015.11.021
复制
发表时间:
2016-02-01
影响因子:
3.6
通讯作者:
Wang, Linlin
中科院分区:
文献类型:
--
作者:
Dong, Taotao;Yang, Dong;Wang, Linlin
In this paper, we aimed to explore whether progranulin (PGRN) could induce epithelial ovarian cancer cells to undergo an epithelial mesenchymal transition (EMT) program directly and through its activation of cancer associated fibroblasts (CAFs) indirectly. Immunohistochemistry(IHC) staining of tissue samples of 78 cases of epithelial ovarian cancer (EOC) patients found that PGRN expression levels were negatively correlated with E-cadherin levels (r = -0.289, P = 0.013) and positively correlated with Slug levels (r = 0.332, P = 0.003); Cell experiments showed that PGRN overexpression could increase the migratory and invasive abilities of A2780 cells significantly. Moreover, high doses (62 ng/ml) of recombinant PGRN could induce 14.7 fold high expression of smooth muscle actin alpha (alpha-SMA) in human normal fibroblasts. In addition, patients with both high levels of PGRN and alpha-SMA in their tissue samples had the worst disease free survival (DFS) and overall survival (OS) than those with low levels of PGRN or alpha-SMA. All the results suggest that PGRN could promote invasiveness of EOC cells through an EMT program directly and through activation of CAFs indirectly. This may provide a new effective therapy target for EOC. (C) 2015 Elsevier Inc. All rights reserved.